Toripalimab and metronomic chemotherapy show efficacy in treating in HER2-negative metastatic breast cancer
Toripalimab and metronomic chemotherapy show efficacy in treating in HER2-negative metastatic breast cancer
Adding nivolumab to R-GemOx shows enhanced efficacy in treating R/R large B-cell lymphoma
Beat AML master trial: A clinical trial for acute myeloid leukaemia
BrECADD combined with PET2-guided treatment sets a new benchmark for the treatment of newly diagnosed advanced-stage cHL
Ponatinib is superior to imatinib in combination with chemotherapy for newly diagnosed Ph+ ALL
SABCS 2023: Latest breast cancer diagnostics guidelines
The evolving paradigm in management of Multiple Myeloma
Introducing oncology to undergraduate medical and allied health sciences students
Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours
Cancer care in Needle Hospital, Hargeisa, Somaliland
Relapsed refractory multiple myeloma
The evolving paradigm in management of Multiple Myeloma